The SCL gene: From case report to critical hematopoietic regulator

Blood

Volumn 93, Issue 9, 1999, Pages 2760-2770

  Begley, C Glenn ^a   Green, Anthony R ^b  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINASE;

ADOLESCENT; CASE REPORT; CELL DIFFERENTIATION; CHROMOSOME BREAKAGE; CHROMOSOME TRANSLOCATION; CYTOGENETICS; ENZYME ACTIVITY; GENE DELETION; GENE LOCATION; GENETIC RECOMBINATION; HEMATOPOIETIC STEM CELL; HUMAN; LEUKEMIA CELL; MALE; PRIORITY JOURNAL; REVIEW; T CELL LEUKEMIA;

EID: 0033135847     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.9.2760.409k44_2760_2770     Document Type: Review

References (141)

1. Hershfield MS, Kurtzberg J, Harden E, Moore JO, Whang-Peng J, Haynes BF: Conversion of a stem cell leukemia from a T-lymphoid to a myeloid phenotype induced by the adenosine deaminase inhibitor 2′-deoxycoformycin. Proc Natl Acad Sci USA 81:253, 1984
2. Kurtzberg J, Bigner SH, Hershfield MS: Establishment of the DU.528 human lymphohemopoietic stem cell line. J Exp Med 162: 1561, 1985
3. Kurtzberg J, Waldmann TA, Davey MP, Bigner SH, Moore JO, Hershfield MS, Haynes BF: CD7+, CD4-, CD8-acute leukemia: A syndrome of malignant pluripotent lymphohematopoietic cells. Blood 73:381, 1989
4. Hata A, Brenner MB, Krangel MS: Identification of putative human T cell receptor delta complementary DNA clones. Science 238:678, 1987
5. Loh EY, Lanier LL, Turck CW, Littman DR, Davis MM, Chien YH, Weiss A: Identification and sequence of a fourth human T cell antigen receptor chain. Nature 330:569, 1987
6. Chien YH, Iwashima M, Kaplan KB, Elliott JF, Davis MM: A new T-cell receptor gene located within the alpha locus and expressed early in T-cell differentiation. Nature 327:677, 1987
7. Boehm T, Baer R, Lavenir I, Forster A, Waters JJ, Nacheva E, Rabbitts TH: The mechanism of chromosomal translocation t(11;14) involving the T-cell receptor (C. delta locus on human chromosome 14q11) and a transcribed region of chromosome 11p15. EMBO J 7:385, 1988
8. Croce CM, Isobe M, Palumbo A, Puck J, Ming J, Tweardy D, Erikson J, Davis M, Rovera G: Gene for alpha-chain of human T-cell receptor: location on chromosome 14 region involved in T-cell neoplasms. Science 227:1044, 1985
9. Begley CG, Aplan PD, Davey MP, Nakahara K, Tchorz K, Kurtzberg J, Hershfeld MS, Haynes BF, Cohen DI, Waldmann TA, Kirsch IR: Chromosomal translocation in a human leukemic stem cell line disrupts the T-cell antigen receptor δ-chain diversity region and results in a previously unreported fusion transcript. Proc Natl Acad Sci USA 86:2031, 1989
10. Begley CG, Aplan PD, Denning SM, Haynes B, Waldmann TA, Kirsch IR: The gene, SCL, is expressed during early hematopoiesis and encodes a differentiation-related DNA-binding motif. Proc Natl Acad Sci USA 86:10128, 1989
11. Finger LR, Kagan J, Christopher G, Kurtzberg J, Hershfield MS, Nowell PC, Croce C: Involvement of the TCL5 gene on chromosome 1 in T-cell leukemia and melanoma. Proc Natl Acad Sci USA 86:5039, 1989
12. Chen Q, Cheng JT, Tsai LH, Schneider N, Buchanan G, Carroll A, Crist W, Ozanne B, Siciliano MJ, Baer R: The tal gene undergoes chromosome translocation in T cell leukemia and potentially encodes a helix-loop-helix protein. EMBO J 9:415, 1990
13. Bernard O, Guglielmi P, Jonveaux P, Cherif D, Gisselbrecht S, Mauchauffe M, Berger R, Larsen CJ, Mathieu-Mahul D: Two distinct mechanisms for the SCL gene activation in the t(1;14) translocation of T-cell leukemias. Genes Chromosomes Cancer 1:194, 1990
14. Begley CG, Aplan PD, Davey MP, de Villartay JP, Cohen DI, Waldmann TA, Kirsch IR: Demonstration of delta rec-pseudo J alpha rearrangement with deletion of the delta locus in a human stem-cell leukemia. J Exp Med 170:339, 1989
15. de Villartay JP, Lewis D, Hockett R, Waldmann TA, Korsmeyer SJ, Cohen DI: Deletional rearrangement in the human T-cell receptor alpha-chain locus. Proc Natl Acad Sci USA 84:8608, 1987
16. de Villartay JP, Hockett RD, Coran D, Korsmeyer SJ, Cohen DI: Deletion of the human T-cell receptor delta-gene by a site-specific recombination. Nature 335:170, 1988
17. Aplan PD, Begley CG, Bertness V, Nussmeier MA, Ezquerra A, Coligan J, Kirsch IR: The SCL gene is formed from a transcriptionally complex locus. Mol Cell Biol 10:6426, 1990
18. Begley CG, Visvader J, Green AR, Aplan PD, Metcalf D, Kirsch IR, Gough NM: Molecular cloning and chromosomal localisation of the murine homolog of the human "helix-loop-helix" gene SCL. Proc Natl Acad Sci USA 88:869, 1991
19. Begley CG, Robb L, Rockman S, Visvader J, Bockamp E-O, Chan YS, Green AR: Structure of the gene encoding the murine SCL protein. Gene 138:93, 1994
20. Breit TM, Wolvers-Tettero IL, van Dongen JJ: Lineage specific demethylation of tal-1 gene breakpoint region determines the frequency of tal-1 deletions in alpha beta lineage T-cells. Oncogene 9:1847, 1994
21. Visvader J, Begley CG, Adams JM: Differential expression of the LYL, SCL and E2A helix-loop-helix genes within the hemopoietic system. Oncogene 6:195, 1991
22. Green AR, Salvaris E, Begley CG: Erythroid expression of the "helix-loop-helix" gene, SCL. Oncogene 6:475, 1991
23. Green AR, Visvader J, Lints T, Harvey R, Begley CG: SCL is co-expressed with GATA-1 in haemopoietic cells but is also expressed in developing brain. Oncogene 7:653, 1992
24. Mouthon M-A, Bernard O, Mitjavila M-T, Romeo P-H, Vainchenker W, Mathieu-Mahul D: Expression of Tal-1 and GATA-binding proteins during human hematopoiesis. Blood 81:647, 1993
25. Mathieu-Mahul D, Bernheim A, Sigaux F, Daniel MT, Larsen CJ, Berger R: Translocation t(1;14) and rearrangement of the gene for the alpha chain of the T-cell receptor in acute T-lymphoblastic leukemia. C R Acad Sci III 302:525, 1986
26. Lampert F, Harbott J, Ritterbach J, Ludwig WD, Fonatsch C, Schwamborn D, Stier B, Gnekow A, Gerein V, Stollmann B: T-cell acute childhood lymphoblastic leukemia with chromosome 14q11 anomaly: A morphologic, immunologic, and cytogenetic analysis of 10 patients. Blut 56:117, 1988
27. Carroll AJ, Crist WM, Link MP, Amylon MD, Pullen DJ, Ragab AH, Buchanan GR, Wimmer RS, Vietti TJ: The t(1;14)(p34;q11) is nonrandom and restricted to T-cell acute lymphoblastic leukemia: A Pediatric Oncology Group study. Blood 76:1220, 1990
28. Bernard O, Lecointe N, Jonveaux P, Souyri M, Mauchauffe M, Berger R, Larsen CJ, Mathieu-Mahul D: Two site-specific deletions and t(1;14) translocation restricted to human T-cell acute leukemias disrupt the 5′ part of the tal-1 gene. Oncogene 6:1477, 1991
29. Bernard O, Barin C, Charrin C, Mathieu-Mahul D, Berger R: Characterization of translocation t(1;14)(p32;q11) in a T and in a B acute leukemia. Leukemia 7:1509, 1993
30. Chen Q, Yang CY, Tsan JT, Ragab AH, Peiper SC, Carroll A, Baer R: Coding sequences of the tal-1 gene are disrupted by chromosome translocation in human T cell leukemia. J Exp Med 172:1403, 1990
31. Xia Y, Brown L, Tsan JT, Yang CY, Siciliano MJ, Crist WM, Carroll AJ, Baer R: The translocation (1;14)(p34;q11) in human T-cell leukemia: Chromosome breakage 25 kilobase pairs downstream of the TAL1 proto oncogene. Genes Chromosomes Cancer 4:211, 1992
32. Aplan PD, Raimondi SC, Kirsch IR: Disruption of the SCL gene by a t(1;3) translocation in a patient with T cell acute lymphoblastic leukemia. J Exp Med 176:1303, 1992
33. Fitzgerald TJ, Geoffrey AM, Neale SC, Raimondi SC, Goorha RM: c-tal, a helix-loop-helix protein, is juxtaposed to the T-cell receptor-β chain gene by a receiprocal chromosomal translocation: t(1;7) (p32;q35). Blood 10:2686, 1991
34. Francois S, Delabesse E, Baranger L, Dautel M, Foussard C, Boasson M, Blanchet O, Bernard O, Macintyre EA, Ifrah N: Deregulated expression of the TAL1 gene by t(1;5)(p32;31) in patient with T-cell acute lymphoblastic leukemia. Genes Chromosomes Cancer 23:36, 1998
35. Brown L, Cheng JT, Chen Q, Siciliano MJ, Crist W, Buchanan G, Baer R: Site-specific recombination of the tal-1 gene is a common occurrence in human T cell leukemia. EMBO J 9:3343, 1990
36. Aplan PD, Lombardi DP, Ginsberg AM, Cossman J, Bertness VL, Kirsch IR: Disruption of the human SCL locus by "illegitimate" V-(D)-J recombinase activity. Science 250:1426, 1990
37. Collazo-Garcia N, Scherer P, Aplan PD: Cloning and characterization of amurine SIL gene. Genomics 30:506, 1995
38. Izraeli S, Colaizzo-Anas T, Bertness VL, Mani K, Aplan PD, Kirsch IR: Expression of the SIL gene is correlated with growth induction and cellular proliferation. Cell Growth Differ 8:1171, 1997
39. Aplan PD, Lombardi DP, Reaman GH, Sather HN, Hammond GD, Kirsch IR: Involvement of the putative hematopoietic transcription factor SCL in T-cell acute lymphoblastic leukemia. Blood 79:1327, 1992
40. Borkhardt A, Repp R, Harbott J, Keller C, Berner F, Ritterbach J, Lampert F: Frequency and DNA sequence of tal-1 rearrangement in children with T-cell acute lymphoblastic leukemia. Ann Hematol 64:305, 1992
41. Breit TM, Mol EJ, Wolvers-Tettero IL, Ludwig WD, van Wering ER, van Dongen JJ: Site-specific deletions involving the tal-1 and sil genes are restricted to cells of the T cell receptor alpha-beta lineage: T cell receptor delta gene deletion mechanism affects multiple genes. J Exp Med 177:965, 1993
42. Janssen JW, Ludwig WD, Sterry W, Bartram CR: SIL-TAL1 deletion in T-cell acute lymphoblastic leukemia. Leukemia 7:1204, 1993
43. Kikuchi A, Hayashi Y, Kobayashi S, Kanada R, Moriwaki K, Yamamoto K, Fujimoto J, Kaneko Y, Yamamori S: Clinical significance of TAL1 gene alteration in childhood T-cell acute lymphoblastic leukemia and lymphoma. Leukemia 7:933, 1993
44. Breit TM, Beishuizen A, Ludwig WD, Mol EJ, Adriaansen HJ, van Wering ER, van Dongen JJ: tal-1 deletions in T-cell acute lymphoblastic leukemia as PCR target for detection of minimal residual disease. Leukemia 7:2004, 1993
45. Bash RO, Hall S, Timmons CF, Crist WM, Amylon M, Smith RG, Baer R: Does activation of the TAL1 gene occur in a majority of patients with T cell acute lymphoblastic leukemia? A pediatric oncology group study. Blood 86:666, 1995
46. Delabesse E, Bernard M, Meyer V, Smit L, Pulford K, Cayuela JM, Ritz J, Bourqueiot P, Strominger JL, Valensi F, Macintyre EA: TAL1 expression does not occur in the majority of T-ALL blasts. Br J Haematol 102:449, 1998
47. Macintyre EA, Smit L, Ritz J, Kirsch IR, Strominger JL: Disruption of the SCL locus in T-lymphoid malignancies correlates with commitment to the T-cell receptor alpha beta lineage. Blood 80:1511, 1992
48. Rockman S, Begley CG, Kannourakis G, Mann GJ, Dobrovic AN, Kefford RF, McGrath K: SCL gene in human tumors. Leukemia 6:623, 1992
49. Shimamoto T, Ohyashiki K, Ohyashiki JH, Kawakubo K, Fujimura T, Iwama H, Nakazawa S, Toyama K: The expression pattern of erythrocyte/megakaryocyte-related transcription factors GATA-1 and the stem cell leukemia gene correlates with hematopoietic differentiation and is associated with outcome of acute myeloid leukemia. Blood 86:3173, 1995
50. Cross MA, Heyworth CM, Murrell AM, Bockamp E-O, Cobley UT, Dexter TM, Green AR: Expression of lineage restricted transcription factors precedes lineage specific differentiation in a multipotent haemopoietic progenitor cell line. Oncogene 9:3013, 1994
51. Green AR, De Luca E, Begley CG: Antisense SCL suppresses self-renewal and enhances spontaneous erythroid differentiation of the human leukaemic cell line K562. EMBO J 10:4153, 1991
52. Elwood NJ, Cook WD, Metcalf D, Begley CG: SCL, the gene implicated in human T-cell leukaemia, is oncogenic in a murine T-lymphocyte cell line. Oncogene 8:3093, 1993
53. Tanigawa T, Elwood N, Metcalf D, Cary D, DeLuca E, Nicola NA: The SCL gene product is regulated by and differentially regulates cytokine responses during myeloid leukemic cell differentiation. Proc Natl Acad Sci USA 90:7864, 1993
54. Tanigawa T, Nicola N, McArthur GA, Strasser A, Begley CG: Differential regulation of macrophage differentiation in response to leukemia inhibitory factor/oncostatin-M/interleukin-6: The effect of enforced expression of the SCL transcription factor. Blood 85:379, 1995
55. Condorelli GL, Tocci A, Botta R, Facchiano F, Testa U, Vitelli L, Valtieri M, Croce CM, Peschle C: Ectopic TAL-1/SCL expression in phenotypically normal or leukemic myeloid precursors: Proliferative and anti-apoptotic effects coupled with a differentiation blockade. Mol Cell Biol 17:2954, 1997
56. Tanigawa T, Robb L, Green AR, Begley CG: Constitutive expression of the putative transcription factor SCL associated with proviral insertion in the myeloid leukemic cell line WEHI-3BD-. Cell Growth Differ 5:557, 1994
57. Li J, Finch RA, Xiao W, Sartorelli AC: Identification of a repressor of the differentiation of WEHI-3B D-leukemia cells. Exp Cell Res 242:274, 1998
58. Aplan PD, Nakahra K, Orkin SH, Kirsch IR: The SCL gene product: A positive regulator of erythroid differentiation. EMBO J 11:4073, 1992
59. Elwood NJ, Zogos H, Pereira DS, Dick JE, Begley CG: Enhanced megakaryocyte and erythroid development from normal human CD34+ cells: Consequence of enforced expression of SCL. Blood 91:3756, 1998
60. Valtieri M, Tocci A, Gabbianelli M, Luchetti L, Masella B, Vitelli L, Botta R, Testa U, Condorelli GL, Peschle C: Enforced TAL-1 expression stimulates primitive, erythroid and megakaryocytic progenitors but blocks the granulopoietic differentiation program. Cancer Res 58:562, 1998
61. Leroy-Viard K, Vinit M-A, Lecointe N, Jouault H, Hidner U, Romeo P-H, Mathieu-Mahul D: Loss of TAL-1 protein activity induces premature apoptosis of Jurkat leukemic T cells upon medium depletion. EMBO J 14:2341, 1995
62. Condorelli GL, Facchiano F, Valtieri M, Proietti E, Vitelli L, Lulli V, Huebner K, Peschle C, Croce CM: T-cell-directed TAL-1 expression induces T-cell malignancies in transgenic mice. Cancer Res 56:5113, 1996
63. Robb L, Rasko JEJ, Bath ML, Strasser A, Begley CG: SCL, a gene frequently activated in human T cell leukaemia does not induce lymphomas in transgenic mice. Oncogene 10:205, 1995
64. Larson RC, Lavenir I, Larson TA, Baer R, Warren AJ, Wadman I, Nottage K, Rabbitts TH: Protein dimerization between Lmo2 (Rbtn2) and Tal1 alters thymocyte development and potentiates T cell tumorigenesis in transgenic mice. EMBO J 15:1021, 1996
65. Aplan PD, Jones CA, Chervinsky DS, Zhao XF, Ellsworth M, Wu CZ, McGuire EA, Gross KW: An scl gene product lacking the transactivation domain induces bony abnormalities and cooperates with LMO1 to generate T-cell malignancies in transgenic mice. EMBO J 16:2408, 1997
66. Kelliher MA, Seldin DC, Leder P: TaI-1 induces T cell acute lymphoblastic leukemia accelerated by casein kinase IIalpha. EMBO J 15:5160, 1996
67. Curtis DJ, Robb L, Strasser A, Begley CG: The CD2-scl transgene alters the phenotype and frequency of T-lymphomas in N-ras transgenic or p53 deficient mice. Oncogene 15:2975, 1997
68. Lowsky R, DeCoteau JF, Reitmair AH, Ichinohasama R, Dong WF, Xu Y, Mak TW, Kadin ME, Minden MD: Defects of the mismatch repair gene MSH2 are implicated in the development of murine and human lymphoblastic lymphomas and are associated with the aberrant expression of rhombotin-2 (Lmo-2) and TaI-1 (SCL). Blood 89:2276, 1997
69. Hsu H-L, Wadman I, Baer R: Formation of in vivo complexes between the TAL1 and E2A polypeptides of leukemic T cells. Proc Natl Acad Sci USA 91:3181, 1994
70. Voronova AF, Lee F: The E2A and tal-1 helix-loop-helix proteins associate in vivo and are modulated by Id proteins during interleukin 6-induced myeloid differentiation. Proc Natl Acad Sci USA 91:5952, 1994
71. Condorelli G, Vitelli L, Valtieri M, Marta I, Montesoro E, Lulli V, Baer R, Peschle C: Coordinate expression and developmental role of Id2 protein and TAL1/E2A heterodimer in erythroid progenitor differentiation. Blood 86:164, 1995
72. Nielsen AL, Norby PL, Pedersen FS, Jorgensen P: E-box sequence and context-dependent TAL1/SCL modulation of basic helix-loop-helix protein-mediated transcriptional activation. J Biol Chem 271:31463, 1996
73. Valge-Archer VE, Osada H, Warren AJ, Forster A, Li J, Baer R, Rabbitts TH: The LIM proteins RBTN2 and the basic helix-loop-helix protein TAL-1 are present in a complex in erythroid cells. Proc Natl Acad Sci USA 91:8617, 1994
74. Wadman IA, Osada H, Grutz GG, Agulnick AD, Westphal H, Forster A, Rabbitts TH: The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldbl/NL1 proteins. EMBO J 16:3145, 1997
75. Cohen-Kaminsky S, Maouche-Chretien L, Vitelli L, Vinit MA, Blanchard I, Yamamoto M, Peschle C, Romeo PH: Chromatin immunoselection defines a TAL-1 target gene. EMBO J 17:5151, 1998
76. Grutz GG, Bucher K, Lavenir I, Larson T, Larson R, Rabbitts TH: The oncogenic T cell LIM-protein Imo2 forms part of a DNA-binding complex specifically in immature T cells. EMBO J 17:4594, 1998
77. Goldfarb AN, Lewandowska K: Inhibition of cellular differentiation by the SCL/tal oncoprotein: Transcriptional repression by an Id-like mechanism. Blood 85:465, 1995
78. Park ST, Sun XH: The Tall oncoprotein inhibits E47-mediated transcription. Mechanism of inhibition. J Biol Chem 273:7030, 1998
79. Hofmann TJ, Cole MD: The TAL1/Scl basic helix-loop-helix protein blocks myogenic differentiation and E-box dependent transactivation. Oncogene 13:617, 1996
80. Bain G, Engel I, Robanus Maandag EC, te Riele HP, Voland JR, Sharp LL, Chun J, Huey B, Pinkel D, Murre C: E2A deficiency leads to abnormalities in alphabeta T-cell development and to rapid development of T-cell lymphomas. Mol Cell Biol 17:4782, 1997
81. Johnson SE, Wang X, Hardy S, Taparowsky EJ, Konieczny SF: Casein kinase II increases the transcriptional activities of MRF4 and MyoD independently of their direct phosphorylation. Mol Cell Biol 16:1604, 1996
82. Robb L, Begley CG: The SCL/TAL1 gene: roles in normal and malignant haematopoiesis. Bioessays 19:607, 1997
83. Murre C, McCaw PS, Baltimore D: A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD and myc proteins. Cell 56:777, 1989
84. Davis RL, Weintraub H: Acquisition of myogenic specificity by replacement of three amino acid residues from MyoD into E12. Science 256:1027, 1992
85. Hsu HL, Huang L, Tsan JT, Funk W, Wright WE, Hu JS, Kingston RE, Baer R: Preferred sequences for DNA recognition by the TAL1 helix-loop-helix proteins. Mol Cell Biol 14:1256, 1994
86. Drake CJ, Brandt SJ, Trusk TC, Little CD: TAL1/SCL is expressed in endothelial progenitor cells/angioblasts and defines a dorsal-to-ventral gradient of vasculogenesis. Dev Biol 192:17, 1997
87. Kallianpur AR, Jordan JE, Brandt SJ: The SCL/TAL-1 gene is expressed in progenitors of both the hematopoietic and vascular systems during embryogenesis. Blood 83:1200, 1994
88. Chiba T, Nagata Y, Kishi A, K. S, Miyajima A, Yamamoto M, Engel JD, Todokoro K: Induction of erythroid-specific gene expression in lymphoid cells. Proc Natl Acad Sci USA 90:11593, 1993
89. Prasad KS, Jordan JE, Koury MJ, Bondurant MC, Brandt SJ: Erythropoietin stimulates transcription of the TAL1/SCL gene and phosphorylation of its protein products. J Biol Chem 270:11603, 1995
90. Hoang T, Paradis E, Brady G, Billia F, Nakahara K, Iscove NN, Kirsch IR: Opposing effects of the basic helix-loop-helix transcription factor SCL on erythroid and monocytic differentiation. Blood 87:102, 1996
91. Murrell AM, Bockamp E-O, Göttgens B, Chan YS, Goss MA, Hey worth CM, Green AR: Discordant regulation of SCL/TAL-1 mRNA and protein during erythroid differentiation. Oncogene 11:131, 1995
92. Green AR, Rockman S, De Luca E, Begley CG: Induced myeloid differentiation of K562 cells with down-regulation of erythroid and megakaryocytic transcription factors; a novel experimental model for haemopoietic lineage restriction. Exp Haematol 21:525, 1993
93. Robb L, Lyons I, Li R, Hartley L, Kontgen F, Harvey RP, Metcalf D, Begley CG: Absence of yolk sac hematopoiesis from mice with a targeted disruption of the scl gene. Proc Natl Acad Sci USA 92:7075, 1995
94. Shivdasani RA, Mayer EL, Orkin SH: Absence of blood formation in mice lacking the T-cell leukemia oncoprotein tal-1/SCL. Nature 373:432, 1995
95. Robb L, Elwood NJ, Elefanty AG, Köntgen F, Li R, Barnett LD, Begley CG: The SCL gene product is required for the generation of all hematopoietic lineages in the adult mouse. EMBO J 15:4123, 1996
96. Porcher C, Swat W, Rockwell K, Fujiwara Y, Alt FW, Orkin SH: The T cell leukemia oncoprotein SCL/tal-1 is essential for development of all hematopoietic lineages. Cell 86:47, 1996
97. Elefanty AG, Robb L, Bimer R, Begley CG: Hematopoietic-specific genes are not induced during in vitro differentiation of scl-null embryonic stem cells. Blood 90:1435, 1997
98. Elefanty AG, Begley CG, Metcalf D, Barnett L, Köntgen F, Robb L: Characterisation of hematopoietic progenitor cells that express the transcription factor SCL, using a lacZ 'knock-in' strategy. Proc Natl Acad Sci 95:11897, 1998
99. Green T: Hematopoiesis - Master regulator unmasked. Nature 383:575, 1996
100. Warren AJ, Colledge WH, Carlton MB, Evans MJ, Smith AJ, Rabbitts TH: The oncogenic cysteine-rich LIM domain protein Rbtn2 is essential for erythroid development. Cell 78:45, 1994
101. Yamada Y, Warren AJ, Dobson C, Forster A, Pannell R, Rabbitts TH: The T cell leukemia LIM protein Lmo2 is necessary for adult mouse hematopoiesis. Proc Natl Acad Sci USA 95:3890, 1998
102. Sabin FR: Studies on the origin of blood vessels and of red blood corpuscles as seen in the living blastoderm of chicks during the second day of incubation. Contrib Embryol 36:213, 1920
103. Murray PDF: The development in vitro of the blood of the early chick embryo. Proc R Soc B 111:497, 1932
104. Wagner RC: Endothelial cell embryology and growth. Adv Microcirc 9:45, 1980
105. Godin IE, Garcia-Porrero JA, Coutinho A, Dieterlen-Lievre F, Marcos MAR: Para-aortic splanchnopleura from early mouse embryos contains B1a cell progenitors. Nature 364:67, 1993
106. Godin I, Dieterlen-Lievre F, Cumano A: Emergence of multipotent hemopoietic cells in the yolk sac and paraaortic splanchnopleura in mouse embryos, beginiing at 8.5 days postcoitus. Proc Natl Acad Sci USA 92:773, 1995
107. Medvinsky AL, Samoylina NL, Muller AM, Dzierzak EA: An early pre-liver intra-embryonic source of CFU-S in the developing mouse. Nature 364:64, 1993
108. Cumano A, Dieterlen-Lievre F, Godin I: Lymphoid potential, probed before circulation in mouse, is restricted to caudal intraembryonic splanchnopleura. Cell 86:907, 1996
109. Medvinsky A, Dzierzak E: Definitive hematopoiesis is autonomously initiated by the AGM region. Cell 86:897, 1996
110. Tavian M, Coulombel L, Luton D, San Clemente H, Dieterlen-Lievre F, Péault B: Aorta-associated CD34+ hematopoietic cells in the early human embryo. Blood 87:67, 1996
111. Wood HB, May G, Healy L, Enver T, Morriss-Kay GM: CD34 expression patterns during early mouse development are related to modes of blood vessel formation and reveal additional sites of hematopoiesis. Blood 90:2300, 1997
112. Pardanaud L, Luton D, Prigent M, L-M B, Catala M, Dieterlen-Lievre F: Two distinct endothelial lineages in ontogeny, one of them related to hemopoiesis. Development 122:1363, 1996
113. Fina L, Molgaard HV, Robertson D, Bradley NJ, Monaghan P, Delia D, Sutherland DR, Baker MA, Greaves MF: Expression of the CD34 gene in vascular endothelial cells. Blood 75:2417, 1990
114. Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML, Schuh AC: Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376:62, 1995
115. Shalaby F, Ho J, Stanford WL, Fischer K-D, Schuh AC, Schwartz L, Bernstein A, Rossant J: A requirement for Flk1 in primitive and definitive hematopoiesis and vasculogenesis. Cell 89:981, 1997
116. Kennedy M, Firpo M, Choi K, Wall C, Robertson S, Kabrun N, Keller G: A common precursor for primitive erythropoiesis and definitive haematopoiesis. Nature 386:488, 1997
117. Eichmann A, Corbel C, Nataf V, Vaigot P, Bréant C, Le Douarin NM: Ligand-dependent development of the endothelial and hemopoietic lineages from embryonic mesodermal cells expressing vascular endothelial growth factor receptor 2. Proc Natl Acad Sci USA 94:5141, 1997
118. Liao W, Bisgrove BW, Sawyer H, Hug B, Bell B, Peters K, Grunwald DJ, Stainier DYR: The zebrafish gene cloche acts upstream of a flk-1 homologue to regulate endothelial cell differentiation. Development 124:381, 1997
119. Hwang L-Y, Siegelman M, Davis L, Oppenheimer-Marks N, Baer R: Expression of the TAL-1 proto-oncogene in cultured endothelial cells and blood vessels of the spleen. Oncogene 8:3043, 1993
120. Visvader JE, Fujiwara Y, Orkin SH: Unsuspected role for the T-cell leukemia protein SCL/tal-1 in vascular development. Genes Dev 12:473, 1998
121. Liao EC, Paw BH, Oates AC, Pratt SJ, Postlethwait JH, Zon LI: SCL/Tal-1 transcription factor acts downstrem of cloche to specify hematopoietic and vascular progenitors in zebrafish. Genes Dev 12:621, 1998
122. Gering M, Rodaway ARF, Göttgens B, Patient RK, Green AR: The SCL gene specifies haemangioblast development from early mesoderm. EMBO J 17:4029, 1998
123. Jan YH, Jan LY: HLH proteins, fly neurogenesis, and vertebrate myogenesis. Cell 75:827, 1993
124. Weintraub H: The Myo D family and myogenesis: Redundancy, networks and thresholds. Cell 75:1241, 1993
125. Jen Y, Weintraub H, Benezra R: Overexpression of Id protein inhibits the muscle differentiation program: In vivo association of Id with E2A proteins. Genes Dev 6:1466, 1992
126. Goldfarb AN, Goueli S, Mickelson D, Greenberg JM: T-cell acute lymphoblastic leukemia - The associated gene SCL/tal codes for a 42-kD nuclear phosphoprotein. Blood 58:537, 1992
127. Cheng J-T, Hsu H-L, Hwang L-Y, Baer R: Products of the TAL-1 oncogene: Basic helix-loop-helix proteins phosphorylated at serine residues. Oncogene 8:677, 1993
128. Elwood NJ, Green AR, Melder A, Visvader J, Begley CG, Nicola N: The SCL protein displays cell-specific heterogeneity in size. Leukemia 8:106, 1994
129. Mead PE, Kelley CM, Hahn PS, Piedad O, Zon L: SCL specifies hematopoietic mesoderm in Xenopus embryos. Development 125:2611, 1998
130. Miller BA, Floros J, Cheung JY, Wojchowski DM, Bell L, Begley CG, Elwood NJ, Kreider J, Christian C: Steel factor affects SCL expression during normal erythroid differentiation. Blood 84:2971, 1994
131. Zhang MY, Clawson GA, Olivieri NF, Bell LL, Begley CG, Miller BA: Expression of SCL is normal in transfusion-dependent Diamond-Blackfan anemia but other bHLH proteins are deficient. Blood 90:2068, 1997
132. Cheng J-T, Cobb MH, Baer R: Phosphorylation of the TAL-1 oncoprotein by the extracellular-signal-regulated protein kinase ERK1. Mol Cell Biol 13:801, 1993
133. Bernard O, Azogui O, Lecointe N, Mugneret F, Berger R, Larsen CJ, Mathieu-Mahul D: A third tal-1 promoter is specifically used in human T cell leukemias. J Exp Med 176:919, 1992
134. Krosl G, He G, Lefrancois M, Charron F, Romeo PH, Jolicoeur P, Kirsch IR, Nemer M, Hoang T: Transcription factor SCL is required for c-kit expression and c-Kit function in hemopoietic cells. J Exp Med 188:439, 1998
135. Enver T, Greaves M: Loops, lineage, and leukemia. Cell 94:9, 1998
136. Lecointe N, Bernard O, Naert K, Joulin V, Larsen CJ, Romeo PH, Mathieu-Mahul D: GATA-and SP1-binding sites are required for the full activity of the tissue-specific promoter of the tal-1 gene. Oncogene 9:2623, 1994
137. Bockamp E-O, McLaughlin F, Murrell AM, Göttgens B, Robb L, Begley CG, Green AR: Lineage-restricted regulation of the murine SCL/TAL-1 promoter Blood 86:1502, 1995
138. Bockamp EO, McLaughlin F, Göttgens B, Murrell AM, Elefanty AG, Green AR: Distinct mechanisms direct SCL/tal-1 expression in erythroid cells and CD34 positive primitive myeloid cells. J Biol Chem 272:8781, 1997
139. Bockamp E-O, Fordham JL, Göttgens B, Murrell AM, Green AR: Transcriptional regulation of the stem cell leukaemia gene by PU.1 and ELF-1. J Biol Chem 273:29032, 1998
140. Leroy-Viard K, Vinit M-A, Lecointe N, Mathieu-Mahul D, Romeo P-H: Distinct DNase-I hypersensitive sites are assocaited with TAL-1 transcription in erythroid and T-cell lines. Blood 84:3619, 1994
141. Göttgens B, McLaughlin F, Bockamp EO, Fordham JL, Begley CG, Kosmopoulos K, Elefanty AG, Green AR: Transcription of the SCL gene in erythroid and CD34 positive primitive myeloid cells is controlled by a complex network of lineage-restricted chromatin-dependent and chromatin-independent regulatory elements. Oncogene 15:2419, 1997